Stock screenerAll disclosures →
EDGAR →
LIXT
Conviction 72HealthcareScan · Thu, Jun 25, 2026Three outside down
LIXT$6.67-2.98%
ResistanceSupportVol 14Vol MA14 458.82K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price6.67
Change-2.98%
Gap-1.82%
Rel volume0.45×
Avg volume404.93K
Avg $ vol2.83M
SMA 206.88
SMA 505.42
SMA 2004.26
Price vs 50+23.06%
Price vs 200+56.56%
MA stackbullish
50/200 cross—
Supertrendup · 5.08
RSI (14)53
MACD hist-0.10
MACD cross—
Stoch %K / %D41 / 56
ADX (14)24
+DI / −DI18 / 16
RSI divergenceBearish
MACD divergenceBearish
ATR %+10.81%
ADR %11.18%
52w high7.61
52w low0.7146
From 52w high-12.42%
Above 52w low+832.69%
New 52w highNo
SqueezeOn · 2d
Bollinger width23.25%
%B0.37
Donchian pos43.69%
Donchian high7.78
Donchian low5.80
AVWAP (52w high)7.28
vs AVWAP high-8.44%
AVWAP (52w low)3.04
vs AVWAP low+119.14%
OBV trendFlat
Chaikin MF (20)0.16
Today vs 20d0.45×
Avg vol (14d)458.82K
Avg vol (20d)404.93K
Avg $ vol (20d)2.83M
Market cap82.53M
RS 3m (vs SPY)+142.19%
RS 6m (vs SPY)+51.29%
RS line new highNo
Trend template6/8
Technical rank85.3
1 week-4.24%
1 month+17.96%
3 months+122.91%
6 months+59.83%
1 year+666.97%
YTD+73.57%
P/E-13.58
P/B10.39
P/S412.66
P/FCF—
EPS-1.26
Div yield—
ROE-76.51%
ROA-55.95%
Debt/Eq—
Current2.78
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-69.51%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value79.12M
Revenue0
Net income-1.98M
Gross profit—
Free cash flow—
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out15.02M
Employees3
ListedWed, Sep 5, 2007
Free float11.61M
Float %99.9%
Short interest246.97K
Days to cover2.2d
Short volume43.3%
Squeeze score17 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeB
Conviction72 / 100
Pattern quality—
Tech rank85.3 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmThree outside down
News sentiment—
Financials as of Tue, Sep 30, 2025 · quarterly.
Congress activity
Disclosed STOCK Act trades in LIXT
No recent disclosed trades by Congress in LIXT. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in LIXT · 5 buys · 5 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Porter Stuart D Director · Common Stock · 2026-05-29 | Grant | 25K | $0 | 2026-05-29 | 2026-06-01 |
Holloway Michael Andrew Director · Options to Purchase Common Stock · 2026-04-15 | Disposition | 25K | — | 2026-04-15 | 2026-04-17 |
Pursglove Geordan Garrett CEO and Chairman of the Board · Common Stock · 2026-04-15 | Grant | 350K | — | 2026-04-15 | 2026-04-17 |
Felix Lourdes Director · Stock Option (right to buy) · 2026-04-15 | Disposition | 25K | — | 2026-04-15 | 2026-04-17 |
Pursglove Geordan Garrett CEO and Chairman of the Board · Options to Purchase Common Stock · 2026-04-15 | Disposition | 350K | — | 2026-04-15 | 2026-04-17 |
Primus Guy Warren Director · Common Stock · 2026-04-15 | Grant | 25K | — | 2026-04-15 | 2026-04-17 |
Stazzone Peter Chief Financial Officer · Options to Purchase Common Stock · 2026-04-15 | Disposition | 50K | — | 2026-04-15 | 2026-04-17 |
Sawyer Jason David Director · Common Stock · 2026-04-15 | Grant | 25K | — | 2026-04-15 | 2026-04-17 |
Holloway Michael Andrew Director · Common Stock · 2026-04-15 | Grant | 25K | — | 2026-04-15 | 2026-04-17 |
Primus Guy Warren Director · Stock Option (right to buy) · 2026-04-15 | Disposition | 25K | — | 2026-04-15 | 2026-04-17 |
SEC filings
EDGAR filings in LIXT · 6 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.